CivaDerm— 510(k) K191324

Substantially Equivalent

Civatech Oncology, Inc.

FDA 510(k) clearance K191324 for CivaDerm, Substantially Equivalent on 2019-09-20. Applicant: Civatech Oncology, Inc..

Clearance details

Applicant: Civatech Oncology, Inc.
Product code: Code KXK
Advisory panel: Radiology
Date received: 2019-05-16
Decision date: 2019-09-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Durham, NC, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.